The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: SLC26A4 vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000441.1(SLC26A4):c.1069G>A (p.Ala357Thr)

CA132654

43491 (ClinVar)

Gene: SLC26A4
Condition: Pendred syndrome
Inheritance Mode: Autosomal recessive inheritance
UUID: ff136dc4-4d43-4577-beb7-70c08e9c04ab
Approved on: 2025-02-19
Published on: 2025-03-18

HGVS expressions

NM_000441.1:c.1069G>A
NM_000441.1(SLC26A4):c.1069G>A (p.Ala357Thr)
NC_000007.14:g.107689120G>A
CM000669.2:g.107689120G>A
NC_000007.13:g.107329565G>A
CM000669.1:g.107329565G>A
NC_000007.12:g.107116801G>A
NG_008489.1:g.33486G>A
ENST00000644269.2:c.1069G>A
ENST00000265715.7:c.1069G>A
NM_000441.2:c.1069G>A
More

Likely Benign

Met criteria codes 2
BS1 PP3
Not Met criteria codes 10
BA1 BP4 BP1 BP5 PS4 PS1 PP2 PM2 PM1 PM5

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Hearing Loss Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for CDH23, COCH, GJB2, KCNQ4, MYO6, MYO7A, SLC26A4, TECTA and USH2A Version 2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hearing Loss VCEP
The filtering allele frequency of the c.1069G>A (p.Ala357Thr) variant in the SLC26A4 gene is 0.46% for African/African American chromosomes by gnomAD v4.1.0 (489/1613848 with 95% CI), which is a high enough frequency to be classified as likely benign based on the thresholds defined by the ClinGen Hearing Loss Expert Panel (HL VCEP) for autosomal recessive hearing loss variants (BS1). The REVEL computational prediction analysis tool produced a score of 0.849, which is above the threshold necessary to apply PP3. The HL VCEP allows classification of variants as likely benign with only BS1 if no other criteria are in conflict. The HL EP reviewed the conflicting evidence (PP3) and felt it did not override the Likely Benign classification in​ this case as computational scores are error prone, especially when predicting pathogenicity. In summary, the HL VCEP classified this variant as likely benign. (BS1, PP3; Clingen Hearing Loss VCEP Specifications Version 2; 02/19/2025).
Met criteria codes
BS1
The filtering allele frequency of the c.1069G>A (p.Ala357Thr) variant in the SLC26A4 gene is 0.46% for African/African American chromosomes by gnomAD v4.1.0 (489/1613848 with 95% CI), which is a high enough frequency to be classified as likely benign based on the thresholds defined by the ClinGen Hearing Loss Expert Panel (HL VCEP) for autosomal recessive hearing loss variants (BS1).
PP3
The REVEL computational prediction analysis tool produced a score of 0.849, which is above the threshold necessary to apply PP3.
Not Met criteria codes
BA1
The filtering allele frequency of the c.1069G>A (p.Ala357Thr) variant in the SLC26A4 gene is 0.46% for African/African American chromosomes by gnomAD v4.1.0 (489/1613848 with 95% CI), which is a high enough frequency to be classified as likely benign based on the thresholds defined by the ClinGen Hearing Loss Expert Panel (HL VCEP) for autosomal recessive hearing loss variants (BS1).
BP4
The REVEL computational prediction analysis tool produced a score of 0.849, which is above the threshold necessary to apply PP3.
BP1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP5
One LMM internal case of an African American individual with congenital profound SNHL with hypothyroidism and a family history of HL is heterozygous for the p.Ala357Thr variant, and carries two other variants in SLC26A4 that were determined to be pathogenic and causative. BP5 not met however, because parental testing was not performed to confirm which variants are in cis/trans.
PS4
The p.Ala357Thr variant was observed by the Partners Lab for Molecular Medicine as heterozygous in two individuals with hearing loss and related syndromes, with no other causative variants identified. A third case was identified with congenital profound sensorineural hearing loss with hypothyroidism and a family history of hearing loss, who carries the variant on one alleles. However, two other pathogenic SLC26A4 variants were observed in this proband and determined to be likely causative of disease. EGL Diagnostics observed the variant in heterozygosity in one hearing loss individual, however no other pathogenic or likely path. variants were identified.
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM2
The filtering allele frequency of the c.1069G>A (p.Ala357Thr) variant in the SLC26A4 gene is 0.46% for African/African American chromosomes by gnomAD v4.1.0 (489/1613848 with 95% CI), which is a high enough frequency to be classified as likely benign based on the thresholds defined by the ClinGen Hearing Loss Expert Panel (HL VCEP) for autosomal recessive hearing loss variants (BS1).
PM1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.